HSIC

Henry Schein, Inc. NASDAQ

Healthcare ·Medical - Distribution ·US · henryschein.com

$73.93

After hrs $72.02 +0.00%

Mkt Cap $9.0B

52w Low $61.95 43.8% of range 52w High $89.29

50d MA $76.72 200d MA $72.55

P/E (TTM) 22.5x

EV/EBITDA 12.7x

P/B 1.9x

Debt/Equity 1.1x

ROE 12.3%

P/FCF 16.1x

RSI (14) —

ATR (14) —

Beta 0.88

50d MA $76.72

200d MA $72.55

Avg Volume 1.3M

About

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-co…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 24, 2026	AMC	1.30	1.34	+3.1%	83.35	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%	-11.6%	—
Nov 4, 2025	AMC	1.27	1.38	+8.7%	71.61	-0.2%	+0.6%	-2.2%	+0.4%	+1.9%	+2.2%	+2.4%	—
Aug 5, 2025	AMC	1.18	1.10	-6.8%	64.83	-0.0%	+2.3%	+1.7%	+1.7%	+2.0%	+4.1%	+4.6%	—
May 5, 2025	AMC	1.11	1.15	+3.6%	66.58	+0.6%	-0.5%	-0.0%	+3.5%	+3.1%	+5.8%	+5.7%	—
Feb 25, 2025	AMC	1.23	1.19	-3.3%	75.82	+0.1%	-4.3%	-4.9%	-4.8%	-6.6%	-7.3%	-8.5%	—
Nov 5, 2024	AMC	1.16	1.22	+5.2%	68.99	+2.9%	+1.5%	+0.6%	-1.4%	-1.0%	-2.2%	+5.1%	—
Aug 6, 2024	AMC	1.22	1.23	+0.8%	63.92	+1.4%	+2.9%	+6.6%	+7.9%	+6.2%	+8.6%	+9.3%	—
May 7, 2024	AMC	1.02	1.10	+7.8%	71.20	+0.5%	+2.2%	+3.1%	+3.0%	+2.7%	+2.2%	-3.7%	—
Feb 27, 2024	AMC	0.70	0.66	-5.7%	77.85	+0.4%	-1.7%	-1.8%	-1.2%	-1.4%	-3.1%	-3.0%	—
Nov 13, 2023	AMC	1.32	1.32	+0.0%	67.50	+0.8%	+2.1%	+0.1%	+1.9%	+1.9%	+1.6%	+9.7%	—
Aug 7, 2023	AMC	1.28	1.31	+2.3%	75.87	-0.3%	+0.1%	+2.0%	+0.8%	+1.0%	+1.6%	-2.3%	—
May 9, 2023	AMC	1.24	1.21	-2.4%	74.83	+0.6%	+1.9%	+2.8%	+2.1%	+4.5%	+3.0%	+0.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 24	Morgan Stanley	Maintains	Underweight → Underweight	—	$78.22	$78.02	-0.3%	-0.9%	-1.3%	-2.7%	-5.7%	-4.6%
Apr 8	Evercore ISI	Maintains	Outperform → Outperform	—	$73.85	$73.91	+0.1%	+2.3%	+2.4%	+2.0%	+2.9%	+4.5%
Feb 25	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$83.35	$82.58	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%
Feb 25	JP Morgan	Maintains	Overweight → Overweight	—	$83.35	$82.58	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%
Feb 25	Morgan Stanley	Maintains	Underweight → Underweight	—	$83.35	$82.58	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%
Feb 25	Mizuho	Maintains	Neutral → Neutral	—	$83.35	$82.58	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%
Feb 25	Barrington Research	Maintains	Outperform → Outperform	—	$83.35	$82.58	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%
Feb 25	Evercore ISI	Maintains	Outperform → Outperform	—	$83.35	$82.58	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%
Feb 25	UBS	Maintains	Neutral → Neutral	—	$83.35	$82.58	-0.9%	-1.7%	-2.3%	-1.2%	-2.4%	-3.8%
Feb 24	Leerink Partners	Maintains	Market Perform → Market Perform	—	$80.57	$84.00	+4.3%	+3.5%	+1.7%	+1.1%	+2.3%	+1.0%
Feb 23	Baird	Upgrade	Neutral → Outperform	—	$79.57	$81.60	+2.6%	+1.3%	+4.8%	+2.9%	+2.4%	+3.5%
Jan 20	Mizuho	Maintains	Neutral → Neutral	—	$79.98	$79.69	-0.4%	-2.8%	-1.3%	-1.9%	-3.5%	-3.0%
Nov 5	Morgan Stanley	Maintains	Underweight → Underweight	—	$71.61	$71.49	-0.2%	+0.6%	-2.2%	+0.4%	+1.9%	+2.2%
Nov 5	Evercore ISI	Maintains	Outperform → Outperform	—	$71.61	$71.49	-0.2%	+0.6%	-2.2%	+0.4%	+1.9%	+2.2%
Nov 5	Barrington Research	Maintains	Outperform → Outperform	—	$71.61	$71.49	-0.2%	+0.6%	-2.2%	+0.4%	+1.9%	+2.2%
Nov 5	JP Morgan	Maintains	Overweight → Overweight	—	$71.61	$71.49	-0.2%	+0.6%	-2.2%	+0.4%	+1.9%	+2.2%
Nov 5	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$71.61	$71.49	-0.2%	+0.6%	-2.2%	+0.4%	+1.9%	+2.2%
Oct 22	Barrington Research	Maintains	Outperform → Outperform	—	$64.23	$64.23	+0.0%	-1.1%	-1.0%	-0.6%	-1.1%	-1.6%
Sep 23	Barrington Research	Maintains	Outperform → Outperform	—	$67.92	$68.13	+0.3%	+1.9%	-0.3%	-3.4%	-2.7%	-2.8%
Aug 26	Evercore ISI	Upgrade	In Line → Outperform	—	$68.47	$69.80	+1.9%	+0.9%	+0.7%	+0.8%	+1.6%	-0.1%
Aug 7	JP Morgan	Maintains	Overweight → Overweight	—	$66.32	$67.08	+1.1%	-0.6%	-0.6%	-0.3%	+1.8%	+4.0%
Aug 6	Barrington Research	Maintains	Outperform → Outperform	—	$64.83	$64.82	-0.0%	+2.3%	+1.7%	+1.7%	+2.0%	+4.1%
Aug 6	Evercore ISI	Maintains	In Line → In Line	—	$64.83	$64.82	-0.0%	+2.3%	+1.7%	+1.7%	+2.0%	+4.1%
Aug 6	UBS	Maintains	Neutral → Neutral	—	$64.83	$64.82	-0.0%	+2.3%	+1.7%	+1.7%	+2.0%	+4.1%
Jul 25	Stifel	Downgrade	Buy → Hold	—	$72.62	$71.96	-0.9%	-1.6%	-3.0%	-3.5%	-4.2%	-6.8%
Jul 14	Baird	Downgrade	Outperform → Neutral	—	$73.42	$70.38	-4.1%	-3.7%	-3.8%	-5.6%	-5.3%	-5.9%
Jul 9	Evercore ISI	Maintains	In Line → In Line	—	$73.95	$74.54	+0.8%	+0.3%	+0.8%	-0.7%	-4.4%	-4.5%
May 6	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$66.58	$66.97	+0.6%	-0.5%	-0.0%	+3.5%	+3.1%	+5.8%
May 6	Barrington Research	Maintains	Outperform → Outperform	—	$66.58	$66.97	+0.6%	-0.5%	-0.0%	+3.5%	+3.1%	+5.8%
Apr 30	Piper Sandler	Maintains	Overweight → Overweight	—	$66.16	$65.39	-1.2%	-1.8%	-2.6%	-1.3%	+0.6%	+0.1%
Feb 26	Barrington Research	Maintains	Outperform → Outperform	—	$75.82	$75.88	+0.1%	-4.3%	-4.9%	-4.8%	-6.6%	-7.3%
Feb 26	UBS	Maintains	Neutral → Neutral	—	$75.82	$75.88	+0.1%	-4.3%	-4.9%	-4.8%	-6.6%	-7.3%
Jan 30	Barrington Research	Maintains	Outperform → Outperform	—	$79.87	$80.46	+0.7%	+0.2%	+0.2%	-0.4%	+0.9%	+2.6%
Jan 23	Jefferies	Maintains	Hold → Hold	—	$74.78	$75.37	+0.8%	-0.0%	+0.3%	+2.6%	+1.8%	+6.8%
Jan 6	BofA Securities	Upgrade	Underperform → Buy	—	$69.09	$71.59	+3.6%	+3.9%	+3.7%	+2.9%	+0.8%	+2.3%
Nov 6	Barrington Research	Maintains	Outperform → Outperform	—	$68.99	$71.00	+2.9%	+1.5%	+0.6%	-1.4%	-1.0%	-2.2%
Oct 8	Evercore ISI	Maintains	In Line → In Line	—	$69.30	$69.34	+0.1%	+1.0%	+1.7%	+1.1%	+1.8%	+2.5%
Sep 20	Barrington Research	Maintains	Outperform → Outperform	—	$72.54	$72.31	-0.3%	-1.9%	-1.3%	-2.5%	-3.7%	-2.3%
Aug 12	JP Morgan	Maintains	Overweight → Overweight	—	$68.94	$68.40	-0.8%	-1.5%	+0.7%	-0.6%	+1.2%	+1.2%
Aug 7	Evercore ISI	Maintains	In Line → In Line	—	$63.92	$64.81	+1.4%	+2.9%	+6.6%	+7.9%	+6.2%	+8.6%
Aug 7	UBS	Maintains	Neutral → Neutral	—	$63.92	$64.81	+1.4%	+2.9%	+6.6%	+7.9%	+6.2%	+8.6%
Aug 7	Baird	Maintains	Outperform → Outperform	—	$63.92	$64.81	+1.4%	+2.9%	+6.6%	+7.9%	+6.2%	+8.6%
Aug 7	Barrington Research	Maintains	Outperform → Outperform	—	$63.92	$64.81	+1.4%	+2.9%	+6.6%	+7.9%	+6.2%	+8.6%
Jul 22	Baird	Upgrade	Neutral → Outperform	—	$70.34	$71.61	+1.8%	+0.9%	-0.5%	-0.1%	+1.0%	+2.8%
Jul 9	Evercore ISI	Maintains	In Line → In Line	—	$64.75	$64.54	-0.3%	-0.5%	-0.9%	+0.5%	+0.6%	+1.7%
Jul 5	Barrington Research	Maintains	Outperform → Outperform	—	$64.79	$64.55	-0.4%	+0.3%	-0.1%	-0.5%	-0.9%	+0.5%
Jun 21	Piper Sandler	Maintains	Overweight → Overweight	—	$66.55	$66.78	+0.3%	+1.1%	+1.1%	-0.7%	-3.0%	-3.7%
May 8	UBS	Maintains	Neutral → Neutral	—	$71.20	$71.53	+0.5%	+2.2%	+3.1%	+3.0%	+2.7%	+2.2%
May 8	Barrington Research	Maintains	Outperform → Outperform	—	$71.20	$71.53	+0.5%	+2.2%	+3.1%	+3.0%	+2.7%	+2.2%
Mar 6	Jefferies	Maintains	Hold → Hold	—	$75.41	$75.78	+0.5%	-0.1%	-0.3%	-0.9%	-0.5%	-1.3%

Recent Filings

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

The departure of an executive effective April 15, 2026 signals potential leadership uncertainty; investors should monitor whether the replacement demonstrates strategic continuity or signals broader organizational concerns affecting these companies' performance.

Apr 14

8-K

Henry Schein Inc -- 8-K Filing

Henry Schein reported Q4 2025 earnings growth with non-GAAP diluted EPS of $1.34 versus $1.19 year-over-year, while guiding 2026 EPS between $5.23-$5.37 with modest 3-5% sales growth.

Feb 24

Data updated apr 25, 2026 2:07pm · Source: massive.com